Brief: Haleos Labs Entered Into Strategic Development Collaboration With Hrv Global Life Sciences
21/01/2026 08:11
Jan 21 (Reuters) - Haleos Labs Ltd HALE.NS: ENTERED INTO STRATEGIC DEVELOPMENT COLLABORATION WITH HRV GLOBAL LIFE SCIENCES COLLABORATION TO ACCELERATE DEVELOPMENT AND GMP MANUFACTURING OF ORPHAN DRUG AND NICHE THERAPEUTIC APIS Source text: ID:nBSE5k4sNj Further company coverage: HALE.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Haleos Labs
See all newsBrief: Haleos Labs Entered Into Strategic Development Collaboration With Hrv Global Life Sciences
SMS Lifesciences India soars; facility gets US FDA clearance
Brief: SMS Lifesciences India Gets EIR With VAI Status From USFDA
Brief: SMS Lifesciences India Dec-Quarter Consol Net Profit Rises
Brief: Sms Lifesciences India Sept-Qtr Consol Net Profit Falls